Bow Hunter’s syndrome is a rare neurological disorder that can cause dizziness, fainting, and other symptoms. It can resolve itself naturally, but it’s treatable if a doctor diagnoses and ...

While Denali plans to submit tivi for accelerated approval early this year, the company is also continuing its investigation of the drug in an ongoing phase 2/3 double-blind, randomized trial in ...

When Hunter syndrome affects the brain, which is about 75% of the time, symptoms usually show up between 18 months and 4 years of age. They start about 2 years later when the disease is milder.

BEDFORD, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the presentation of preclinical data that supports the ...

A Denali Therapeutics drug for the rare enzyme deficiency Hunter syndrome is still in pivotal testing, but the company has guidance from the FDA on a pathway to get this therapy to the market sooner.

On December 3, the International Day of Persons with Disabilities, ABC11 spoke with Dr. Kimberly Stephens whose son Cole was diagnosed with an aggressive disease called Hunter Syndrome when he was ...